Identifying cancer-related microRNAs based on gene expression data

Bioinformatics

Volumn 31, Issue 8, 2015, Pages 1226-1234

  Zhao, Xing Ming ^a   Liu, Ke Qin ^b,c   Zhu, Guanghui ^d   He, Feng ^a   Duval, Beátrice ^c   Richer, Jean Michel ^c   Huang, De Shuang ^a   Jiang, Chang Jun ^a   Hao, Jin Kao ^c   Chen, Luonan ^e  

^a TONGJI UNIVERSITY   (China)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITÉ D'ANGERS   (France)

^d SHANGHAI UNIVERSITY   (China)

^e Chinese Academy of Sciences   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA; TUMOR MARKER;

BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; HUMAN; METABOLISM; NEOPLASMS; PROCEDURES;

COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; MICRORNAS; NEOPLASMS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84927728842     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btu811     Document Type: Article

References (65)

1. Abdelmohsen, K. and Gorospe, M. (2010) Posttranscriptional regulation of cancer traits by HuR. Wiley Interdiscip. Rev. RNA, 1, 214-229.
2. Aigner, K. et al. (2007) The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene, 26, 6979-6988.
3. Akao, Y. et al. (2006) let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol. Pharm. Bull., 29, 903-906.
4. Asangani, I. A. et al. (2008) MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene, 27, 2128-2136.
5. Balaguer, F. et al. (2010) Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis. Cancer Res., 70, 6609-6618.
6. Bartel, D. P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-297.
7. Brenner, B. et al. (2011) MicroRNAs as a potential prognostic factor in gastric cancer. World J. Gastroenterol., 17, 3976-3985.
8. Calin, G. A. and Croce, C. M. (2006) MicroRNA signatures in human cancers. Nat. Rev. Cancer, 6, 857-866.
9. Calin, G. A. et al. (2002) Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl Acad. Sci. USA, 99, 15524-15529.
10. Calin, G. A. et al. (2005) AMicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med., 353, 1793-1801.
11. Chen, D. L. et al. (2013) Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer. Carcinogenesis, 34, 803-811.
12. Chen, X. et al. (2012) RWRMDA: predicting novel human microRNA-disease associations. Mol. Biosyst., 8, 2792-2798.
13. Comijn, J. et al. (2001) The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol. Cell, 7, 1267-1278.
14. Croce, C. M. (2009) Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet., 10, 704-714.
15. D'Errico, M. et al. (2009) Genome-wide expression profile of sporadic gastric cancers with microsatellite instability. Eur. J. Cancer, 45, 461-469.
16. Deng, H. et al. (2013a) MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer. Gene, 518, 351-359.
17. Deng, M. et al. (2013b) miR-26a suppresses tumor growth and metastasis by targeting FGF9 in gastric cancer. PLoS One, 8, e72662.
18. Dixon, D. A. et al. (2001) Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J. Clin. Invest., 108, 1657-1665.
19. Edgar, R. et al. (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res., 30, 207-210.
20. Esteller, M. (2011) Non-coding RNAs in human disease. Nat. Rev. Genet., 12, 861-874.
21. Fabbri, M. et al. (2007) MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl Acad. Sci. USA, 104, 15805-15810.
22. Graham, K. et al. (2010) Gene expression in histologically normal epithelium from breast cancer patients and from cancer-free prophylactic mastectomy patients shares a similar profile. Br J Cancer 2010, 102, 1284-1293.
23. Griffiths-Jones, S. et al. (2006) miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res., 34, D140-D144.
24. Hanahan, D. and Weinberg, R. A. (2011) Hallmarks of cancer: the next generation. Cell, 144, 646-674.
25. Hong, Y. et al. (2010) A 'metastasis-prone' signature for early-stage mismatchrepair proficient sporadic colorectal cancer patients and its implications for possible therapeutics. Clin. Exp. Metastasis, 27, 83-90.
26. Irizarry, R. A. et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics, 4, 249-264.
27. John, B. et al. (2004) Human MicroRNA targets. PLoS Biol., 2, e363.
28. Johnson, S. M. et al. (2005) RAS is regulated by the let-7 microRNA family. Cell, 120, 635-647.
29. Kanehisa, M. et al. (2008) KEGG for linking genomes to life and the environment. Nucleic Acids Res., 36, D480-D484.
30. Klaus, A. and Birchmeier, W. (2008) Wnt signalling and its impact on development and cancer. Nat. Rev. Cancer, 8, 387-398.
31. Krek, A. et al. (2005) Combinatorial microRNA target predictions. Nat. Genet., 37, 495-500.
32. Kuo, T. Y. et al. (2012) Computational analysis of mRNA expression profiles identifies microRNA-29a/c as predictor of colorectal cancer early recurrence. PLoS One, 7, e31587.
33. Landi, M. T. et al. (2008) Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival. PLoS One, 3, e1651.
34. Lee, E. J. et al. (2008) Systematic evaluation of microRNA processing patterns in tissues, cell lines, and tumors. RNA, 14, 35-42.
35. Lewis, B. P. et al. (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 120, 15-20.
36. Li, X. et al. (2011) Prioritizing human cancer microRNAs based on genes' functional consistency between microRNA and cancer. Nucleic Acids Res., 39, e153.
37. Liang, Y. et al. (2007) Characterization of microRNA expression profiles in normal human tissues. BMC Genomics, 8, 166.
38. Liberzon, A. et al. (2011) Molecular signatures database (MSigDB) 3. 0. Bioinformatics, 27, 1739-1740.
39. Lim, L. P. et al. (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature, 433, 769-773.
40. Liu, K. Q. et al. (2012) Identifying dysregulated pathways in cancers from pathway interaction networks. BMC Bioinformatics, 13, 126.
41. Lopez de Silanes, I. et al. (2005) HuR: post-transcriptional paths to malignancy. RNA Biol., 2, 11-13.
42. Lu, J. et al. (2005) MicroRNA expression profiles classify human cancers. Nature, 435, 834-838.
43. Lu, M. et al. (2008) An analysis of human microRNA and disease associations. PLoS One, 3, e3420.
44. Maragkakis, M. et al. (2009) Accurate microRNA target prediction correlates with protein repression levels. BMC Bioinformatics, 10, 295.
45. Matsuo, M. et al. (2013) MiR-29c is downregulated in gastric carcinomas and regulates cell proliferation by targeting RCC2. Mol. Cancer, 12, 15.
46. Matthews, L. et al. (2009) Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Res., 37, D619-D622.
47. Muniyappa, M. K. et al. (2009) MiRNA-29a regulates the expression of numerous proteins and reduces the invasiveness and proliferation of human carcinoma cell lines. Eur. J. Cancer, 45, 3104-3118.
48. Noh, J. H. et al. (2013) MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer. Cancer Lett, 335, 455-462.
49. Oulas, A. et al. (2011) Computational identification of miRNAs involved in cancer. Methods Mol. Biol., 676, 23-41.
50. Pau Ni, I. B. et al. (2010) Gene expression patterns distinguish breast carcinomas from normal breast tissues: the Malaysian context. Pathol Res Pract, 206, 223-228.
51. Park, S. Y. et al. (2009) miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat. Struct. Mol. Biol., 16, 23-29.
52. Sampson, V. B. et al. (2007) MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res., 67, 9762-9770.
53. Sethupathy, P. et al. (2006) TarBase: a comprehensive database of experimentally supported animal microRNA targets. RNA, 12, 192-197.
54. Shell, S. et al. (2007) Let-7 expression defines two differentiation stages of cancer. Proc. Natl Acad. Sci. USA, 104, 11400-11405.
55. Skrzypczak, M. et al. (2010) Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliability. PLoS One, 5, e13091.
56. Srikantan, S. et al. (2011) Translational control of TOP2A influences doxorubicin efficacy. Mol. Cell Biol., 31, 3790-3801.
57. Su, L. J. et al. (2007) Selection of DDX5 as a novel internal control for Q-RTPCR from microarray data using a block bootstrap re-sampling scheme. BMC Genomics, 8, 140.
58. Takamizawa, J. et al. (2004) Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res., 64, 3753-3756.
59. Wang, Q. et al. (2012) Upregulated INHBA expression is associated with poor survival in gastric cancer. Med. Oncol., 29, 77-83.
60. Wu, E. et al. (2008) Comprehensive dissection of PDGF-PDGFR signaling pathways in PDGFR genetically defined cells. PLoS One, 3, e3794.
61. Wu, W. Y. et al. (2011) Potentially predictive microRNAs of gastric cancer with metastasis to lymph node. World J. Gastroenterol., 17, 3645-3651.
62. Wuchty, S. et al. (2013) Important miRs of pathways in different tumor types. PLoS Comput. Biol., 9, e1002883.
63. Yanaihara, N. et al. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell, 9, 189-198.
64. Zhang, W. et al. (2014) Identification of candidate miRNA biomarkers from miRNA regulatory network with application to prostate cancer. J. Transl. Med., 12, 66.
65. Zhao, X. M. et al. (2008) Uncovering signal transduction networks from high-throughput data by integer linear programming. Nucleic Acids Res., 36, e48.